Original Contribution | Published:

Colon/Small Bowel

The Prevalence of Celiac Disease in the United States

The American Journal of Gastroenterology volume 107, pages 15381544 (2012) | Download Citation



The prevalence of celiac disease (CD) in the United States is unknown. We sought to estimate CD prevalence nationwide by using a nationally representative sample.


This study included 7,798 persons aged 6 years or older who participated in the National Health and Nutrition Examination Survey 2009–2010. Serum samples from all participants were tested for immunoglobulin A (IgA) tissue transglutaminase antibodies and, if findings were abnormal, also for IgA endomysial antibodies. Information about prior diagnosis of CD and use of a gluten-free diet (GFD) was obtained by direct interview. CD was defined as having either double-positive serology (serologically diagnosed CD) or a reported diagnosis of CD by a doctor or other health-care professional and being on a GFD (reported clinical diagnosis of CD).


CD was found in 35 participants, 29 of whom were unaware of their diagnosis. Median age was 45 years (interquartile range, 23–66 years); 20 were women and 29 were non-Hispanic white. The prevalence of CD in the United States was 0.71% (95% confidence interval (CI), 0.58–0.86%), with 1.01% (95% CI, 0.78–1.31%) among non-Hispanic whites. In all, 55 participants reported following a GFD, which corresponded to a prevalence of 0.63% (95% CI, 0.36–1.07%).


The prevalence of CD in the United States was 0.71% (1 in 141), similar to that found in several European countries. However, most cases were undiagnosed. CD was rare among minority groups but affected 1% of non-Hispanic whites. Most persons who were following a GFD did not have a diagnosis of CD.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    , . Celiac disease. N Engl J Med 2007;357:1731–1743.

  2. 2.

    , , et al. Prevalence of celiac disease among children in Finland. N Engl J Med 2003;348:2517–2524.

  3. 3.

    , , et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 2009;137:88–93.

  4. 4.

    , , et al. Morbidity and mortality among older individuals with undiagnosed celiac disease. Gastroenterology 2010;139:763–769.

  5. 5.

    , , et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003;163:286–292.

  6. 6.

    , . Update on serologic testing in celiac disease. Am J Gastroenterol 2010;105:2520–2524.

  7. 7.

    , , et al. Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. Gastroenterology 2010;139:112–119.

  8. 8.

    National Health and Nutrition Examination Survey (NHANES). General Information for the Public Files of the 2009–2010 Laboratory Data [Internet]. Centers for Disease Control and Prevention: Atlanta (GA) [updated 30 September 2011; cited November 2011]. Available from: .

  9. 9.

    National Health and Nutrition Examination Surgery (NHANES). Laboratory Procedure Manual: Tissue Transglutaminase Assay (IgA)-IgA (ELISA) [Internet]. Centers for Disease Control and Prevention: Atlanta (GA) [cited November 2011]. Available from: .

  10. 10.

    , , et al. IgA anti-endomysium antibody: a new immunological marker of dermatitis herpetiformis and coeliac disease. Br J Dermatol 1984;111:395–402.

  11. 11.

    National Health and Nutrition Examination Survey (NHANES). 2009–2010 Data Documentation, Codebook, and Frequencies: Tissue Transglutaminase Assay (IgA-TTG) and the IgA Endomyseal Antibody Assay (IgA EMA) (TGEMA_F) [Internet]. Centers for Disease Control and Prevention: Atlanta, GA [cited November 2011]. Available from: .

  12. 12.

    , , et al. Endomysial antibody: is it the best screening test for coeliac disease? Gut 1992;33:1633–1637.

  13. 13.

    , , et al. Increasing prevalence and high incidence of celiac disease in elderly people: a population-based study. BMC Gastroenterol 2009;9:49.

  14. 14.

    , , et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998;115:1322–1328.

  15. 15.

    , , . Endomysium antibodies in coeliac disease: an improved method. Gut 1994;35:776–778.

  16. 16.

    National Health and Nutrition Examination Survey (NHANES). 2009–2010 Questionnaire Files [Internet]. Centers for Disease Control and Prevention: Atlanta, GA [cited November 2011] Available from: .

  17. 17.

    , , et al. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut 2003;52:960–965.

  18. 18.

    , , et al. Prevalence of coeliac disease in Northern Ireland. Lancet 1997;350:1370.

  19. 19.

    , , et al. The coeliac iceberg in Italy: a multicentre antigliadin antibodies screening for coeliac disease in school-age subjects. Acta Paediatr Suppl 1996;412:29–35.

  20. 20.

    , , et al. High prevalence of undiagnosed coeliac disease in adults: a Swedish population-based study. J Intern Med 1999;245:63–68.

  21. 21.

    , , et al. Mass screening for coeliac disease using antihuman transglutaminase antibody assay. Arch Dis Child 2004;89:512–515.

  22. 22.

    , , et al. High prevalence of coeliac disease in a population-based study from Western Australia: a case for screening? Med J Aust 2001;175:247–250.

  23. 23.

    , , et al. Adult coeliac disease: prevalence and clinical significance. J Gastroenterol Hepatol 2000;15:1032–1036.

  24. 24.

    , , et al. Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol 1998;33:494–498.

  25. 25.

    , , et al. The prevalence of celiac disease among patients with nonconstipated irritable bowel syndrome is similar to controls. Gastroenterology 2011;141:1187 .

  26. 26.

    , , et al. HLA-DQ typing in the diagnosis of celiac disease. Am J Gastroenterol 2002;97:695–699.

  27. 27.

    , . Celiac disease genetics: current concepts and practical applications. Clin Gastroenterol Hepatol 2005;3:843–851.

  28. 28.

    , , et al. Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol 2011;106:1333–1339.

  29. 29.

    , , et al. Celiac disease in an urban VA population with iron deficiency: the case against routine duodenal biopsy. Dig Dis Sci 2011;56:2037–2041.

  30. 30.

    , . Celiac disease in African American children with type 1 diabetes mellitus in inner city Brooklyn. Pediatr Endocrinol Rev 2008;5 (Suppl 4): 994–998.

  31. 31.

    , , et al. Celiac disease in African-Americans. Dig Dis Sci 2006;51:1012–1015.

  32. 32.

    , , et al. Celiac disease could be a frequent disease in Mexico: prevalence of tissue transglutaminase antibody in healthy blood donors. J Clin Gastroenterol 2006;40:697–700.

  33. 33.

    , , et al. Trends in the identification and clinical features of celiac disease in a North American community, 1950–2001. Clin Gastroenterol Hepatol 2003;1:19–27.

  34. 34.

    , , et al. Trends in the presentation of celiac disease. Am J Med 2006;119:355.e9–355 e14.

  35. 35.

    , , et al. Detection of celiac disease in primary care: a multicenter case-finding study in North America. Am J Gastroenterol 2007;102:1454–1460.

  36. 36.

    , , . Incidence and prevalence of diagnosed coeliac disease in Finland: results of effective case finding in adults. Scand J Gastroenterol 2009;44:933–938.

  37. 37.

    , , et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol 2001;96:126–131.

  38. 38.

    , , . Systematic review: the evidence base for long-term management of coeliac disease. Aliment Pharmacol Ther 2008;28:1042–1066.

  39. 39.

    , , . Is it time to screen for adult coeliac disease? Eur J Gastroenterol Hepatol 2011;23:833–838.

  40. 40.

    , , . American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 2006;131:1981–2002.

  41. 41.

    , , et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 1998;115:1317–1321.

  42. 42.

    , , et al. Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol 2005;17:85–91.

  43. 43.

    , , et al. Antibodies to human recombinant tissue transglutaminase may detect coeliac disease patients undiagnosed by endomysial antibodies. Aliment Pharmacol Ther 2003;17:1415–1423.

  44. 44.

    , , et al. IgA antibodies to human tissue transglutaminase: audit of routine practice confirms high diagnostic accuracy. Scand J Gastroenterol 2004;39:1078–1082.

  45. 45.

    , , et al. Celiac disease without villous atrophy in children: a prospective study. J Pediatr 2010;157:373–380.

  46. 46.

    , , et al. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study. Gastroenterology 2009;136:816–823.

  47. 47.

    , , et al. Variability in small bowel histopathology reporting between different pathology practice settings: impact on the diagnosis of coeliac disease. J Clin Pathol 2011;65:242–247.

  48. 48.

    , , et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology 2005;128 (4 Suppl 1): S57–S67.

  49. 49.

    . Selective IgA deficiency in blood donors. Vox Sang 1975;29:192–202.

  50. 50.

    , , et al. Serological tests for celiac disease as indicators of long-term compliance with the gluten-free diet. Eur J Gastroenterol Hepatol 2011;23:473–480.

  51. 51.

    , , , et al., Coeliac EU Cluster, Project Epidemiology. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med 2010;42:587–595.

  52. 52.

    , , , et al., New Zealand Asthma and Allergy Cohort Study Group. Coeliac disease and gluten avoidance in New Zealand children. Arch Dis Child 2012;97:12–16.

  53. 53.

    , , .et al. Clinical response to gluten withdrawal is not an indicator of coeliac disease. Scand J Gastroenterol 2008;43:1311–1314.

Download references


We thank Danita Byrd-Clark of Social and Scientific System, Silver Spring, MD for her help with data programming and statistical analysis and the staff of the Immunodermatology Laboratory of Mayo Clinic for indirect immunofluorescence assays.

Author information


  1. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA

    • Alberto Rubio-Tapia
    • , Tricia L Brantner
    •  & Joseph A Murray
  2. Department of Pediatrics, Orebro University Hospital, Orebro, Sweden

    • Jonas F Ludvigsson
  3. Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden

    • Jonas F Ludvigsson
  4. Department of Health and Human Services, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA

    • James E Everhart
  5. J.A.M. and J.E.E. are co-senior authors

    • Joseph A Murray
    •  & James E Everhart


  1. Search for Alberto Rubio-Tapia in:

  2. Search for Jonas F Ludvigsson in:

  3. Search for Tricia L Brantner in:

  4. Search for Joseph A Murray in:

  5. Search for James E Everhart in:

Competing interests

Guarantor of the article: James E. Everhart, MD, MPH and Joseph A. Murray, MD.

Specific author contributions: study concept and design: James E. Everhart and Joseph A. Murray; analysis and interpretation of data, drafting of the manuscript, and critical revision of the manuscript for important intellectual content: Alberto Rubio-Tapia, Jonas F. Ludvigsson, Joseph A. Murray and James E. Everhart; statistical analysis: Alberto Rubio-Tapia and James E. Everhart; obtained funding: James E. Everhart; administrative, technical, or material support: Tricia L. Brantner; study supervision: James E. Everhart and Joseph A. Murray.

Financial support: This work was supported by the Centers for Disease Control Contract No. M26561, American College of Gastroenterology Junior Faculty Development Award (A.R.-T.), the Swedish Research Council and the Fulbright Commission (J.F.L.).

Potential competing interests: None.

Corresponding author

Correspondence to Joseph A Murray.

About this article

Publication history






Further reading